BlossomHill Therapeutics, Inc. (BLSM)
BlossomHill Therapeutics, Inc. (BLSM) Insider Trading
Directors, officers and holders of more than 10% of BLSM report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 43 most recent of 43 transactions on file: 7 with code P, 0 with code S and 36 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | ORBIMED ADVISORS LLC | Director | C Conversion | 1,049,283 | Not measured | Not measured |
| Aug 10, 2026 | Cui Jingrong Jean | President and CEO | C Conversion | 113,435 | Not measured | Not measured |
| Aug 10, 2026 | Cui Jingrong Jean | President and CEO | C Conversion | 124,779 | Not measured | Not measured |
| Aug 10, 2026 | Li Yishan | Executive Chairman | C Conversion | 1,600,682 | Not measured | Not measured |
| Aug 10, 2026 | Li Yishan | Executive Chairman | C Conversion | 113,435 | Not measured | Not measured |
| Aug 10, 2026 | Li Yishan | Executive Chairman | C Conversion | 124,779 | Not measured | Not measured |
| Aug 10, 2026 | Li Yishan | Executive Chairman | C Conversion | 124,779 | Not measured | Not measured |
| Aug 10, 2026 | Liptak Vincent Paul | General Counsel | C Conversion | 22,687 | Not measured | Not measured |
| Aug 10, 2026 | Agrawal Sundeep | Director | C Conversion | 578,524 | Not measured | Not measured |
| Aug 10, 2026 | Chen Bihua | Director | C Conversion | 1,599,993 | Not measured | Not measured |
| Aug 10, 2026 | Chen Bihua | Director | C Conversion | 1,701,541 | Not measured | Not measured |
| Aug 10, 2026 | GORDON CARL L | Director | C Conversion | 1,039,996 | Not measured | Not measured |
| Aug 10, 2026 | GORDON CARL L | Director | C Conversion | 1,049,283 | Not measured | Not measured |
| Aug 10, 2026 | ORBIMED ADVISORS LLC | Director | C Conversion | 1,039,996 | Not measured | Not measured |
| Aug 10, 2026 | Cui Jingrong Jean | President and CEO | C Conversion | 1,600,682 | Not measured | Not measured |
| Aug 10, 2026 | Liptak Vincent Paul | General Counsel | P Purchase | 2,200 | $16.00 | $35,200 |
| Aug 10, 2026 | Liptak Vincent Paul | General Counsel | C Conversion | 22,687 | Not measured | Not measured |
| Aug 10, 2026 | Schmid John P. | Director | P Purchase | 6,000 | $16.00 | $96,000 |
| Aug 10, 2026 | Keyes Jason A | Chief Financial Officer | P Purchase | 700 | $16.00 | $11,200 |
| Aug 10, 2026 | Agrawal Sundeep | Director | C Conversion | 578,524 | Not measured | Not measured |
| Aug 10, 2026 | Chen Bihua | Director | C Conversion | 1,599,993 | Not measured | Not measured |
| Aug 10, 2026 | Chen Bihua | Director | C Conversion | 1,701,541 | Not measured | Not measured |
| Aug 10, 2026 | Chen Bihua | Director | P Purchase | 312,500 | $16.00 | $5,000,000 |
| Aug 10, 2026 | GORDON CARL L | Director | C Conversion | 1,039,996 | Not measured | Not measured |
| Aug 10, 2026 | GORDON CARL L | Director | C Conversion | 1,049,283 | Not measured | Not measured |
| Aug 10, 2026 | GORDON CARL L | Director | P Purchase | 625,000 | $16.00 | $10,000,000 |
| Aug 10, 2026 | ORBIMED ADVISORS LLC | Director | C Conversion | 1,039,996 | Not measured | Not measured |
| Aug 10, 2026 | ORBIMED ADVISORS LLC | Director | C Conversion | 1,049,283 | Not measured | Not measured |
| Aug 10, 2026 | ORBIMED ADVISORS LLC | Director | P Purchase | 625,000 | $16.00 | $10,000,000 |
| Aug 10, 2026 | Cui Jingrong Jean | President and CEO | C Conversion | 1,600,682 | Not measured | Not measured |
| Aug 10, 2026 | Cui Jingrong Jean | President and CEO | C Conversion | 113,435 | Not measured | Not measured |
| Aug 10, 2026 | Cui Jingrong Jean | President and CEO | C Conversion | 124,779 | Not measured | Not measured |
| Aug 10, 2026 | Li Yishan | Executive Chairman | C Conversion | 1,600,682 | Not measured | Not measured |
| Aug 10, 2026 | Li Yishan | Executive Chairman | C Conversion | 113,435 | Not measured | Not measured |
| Aug 7, 2026 | Liptak Vincent Paul | General Counsel | P Purchase | 2,500 | $15.80 | $39,500 |
| Aug 6, 2026 | Chen Bihua | Director | A Award | 23,904 | Not measured | Not measured |
| Aug 6, 2026 | Oxnard Geoffrey Raymond | Chief Medical Officer | A Award | 61,783 | Not measured | Not measured |
| Aug 6, 2026 | Li Yishan | Executive Chairman | A Award | 112,701 | Not measured | Not measured |
| Aug 6, 2026 | Keyes Jason A | Chief Financial Officer | A Award | 56,746 | Not measured | Not measured |
| Aug 6, 2026 | GORDON CARL L | Director | A Award | 23,904 | Not measured | Not measured |
| Aug 6, 2026 | Agrawal Sundeep | Director | A Award | 23,904 | Not measured | Not measured |
| Aug 6, 2026 | Cui Jingrong Jean | President and CEO | A Award | 676,205 | Not measured | Not measured |
| Aug 6, 2026 | Liptak Vincent Paul | General Counsel | A Award | 46,561 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.